Microsoft Corporation594918104US594918104512/05/2025Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")SECTION 14A SAY-ON-PAY VOTES25800.0000000FOR25800.000000FORCisco Systems, Inc.17275R102US17275R102312/16/2025Approval, on an advisory basis, of executive compensation.SECTION 14A SAY-ON-PAY VOTES82878.0000000FOR82878.000000FORApple Inc.037833100US037833100502/24/2026Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTES56800.0000000AGAINST56800.000000AGAINSTSynopsys, Inc.871607107US871607107604/16/2026To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement.SECTION 14A SAY-ON-PAY VOTES10000.0000000FOR10000.000000FORPfizer Inc.717081103US717081103504/23/20262026 advisory approval of executive compensationSECTION 14A SAY-ON-PAY VOTES192000.0000000FOR192000.000000FORVeolia Environnement SA92334N103US92334N103704/23/2026Approve Compensation of Antoine Frerot, Chairman of the BoardSECTION 14A SAY-ON-PAY VOTES1100.0000000FOR1100.000000FORVeolia Environnement SA92334N103US92334N103704/23/2026Approve Compensation of Estelle Brachlianoff, CEOSECTION 14A SAY-ON-PAY VOTES1100.0000000FOR1100.000000FORBristol-Myers Squibb Company110122108US110122108305/05/2026Advisory Vote to Approve the Compensation of our Named Executive OfficersSECTION 14A SAY-ON-PAY VOTES91000.0000000FOR91000.000000FORJackson Financial Inc.46817M107US46817M107105/21/2026Non-binding, Advisory Vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTES39.0000000FOR39.000000FORExelixis, Inc.30161Q104US30161Q104005/26/2026To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTES24000.0000000FOR24000.000000FORAccor SA00435F309US00435F309105/27/2026Approve Compensation of Sebastien Bazin, Chairman and CEOSECTION 14A SAY-ON-PAY VOTES1934.0000000AGAINST1934.000000AGAINSTBioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES18000.0000000FOR18000.000000FORApogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES16000.0000000FOR16000.000000FOR